Skip to main content
Finolex Industries Ltd. logo

Finolex Industries Ltd. — Investor Relations & Filings

Ticker · FINPIPE ISIN · INE183A01024 LEI · 335800DLFD2ERNKIDE17 BSE.NS Manufacturing
Filings indexed 1,862 across all filing types
Latest filing 2024-01-03 Regulatory Filings
Country IN India
Listing BSE.NS FINPIPE

About Finolex Industries Ltd.

https://www.finolexpipes.com/

Finolex Industries Ltd. is a manufacturer of polyvinyl chloride (PVC) pipes and fittings, as well as PVC resin. The company operates a backward-integrated manufacturing model, producing its own PVC resin to ensure quality control and supply consistency for its downstream pipe production. Its product portfolio includes a comprehensive range of PVC-U pipes and fittings designed for applications in agriculture, plumbing, and sanitation. These products support irrigation systems, borewells, and residential and commercial water management. With multiple manufacturing facilities and an extensive distribution network, the company provides fluid management solutions across various sectors. It is characterized by its focus on high-quality standards and technological integration, offering durable products for water transportation and infrastructure development.

Recent filings

Filing Released Lang Actions
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, certifying that details of securities dematerialized/rematerialized during the quarter ended December 31, 2023, have been furnished to stock exchanges. It is signed by the company secretary and includes confirmations from registrars and depository agents. The document is a compliance certificate rather than a financial report or announcement of financial results. It is primarily an officer certification related to regulatory compliance. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS). The document length is 3349 characters, which is relatively short and consistent with a certification letter rather than a full report.
2024-01-03 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, certifying that details of securities dematerialized/rematerialized during the quarter ended December 31, 2023, have been furnished to stock exchanges. It is signed by the Company Secretary and includes confirmation letters from the Registrar and Depository agents. The document is short (3349 characters) and primarily serves as a certification or confirmation letter rather than a financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits the criteria for a Regulatory Filing (RNS), as it is a regulatory compliance certificate rather than a full report or announcement of a report.
2024-01-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the upcoming announcement of unaudited financial results for the quarter and nine months ended 31st December 2023 but does not contain any financial data or the results themselves. The document is only an announcement related to insider trading restrictions ahead of financial results disclosure. Given the short length (1602 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than an Interim Report or Earnings Release. It is not a report or detailed financial document but a regulatory compliance announcement.
2023-12-27 English
Intimation of closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window for insiders ahead of the announcement of the company's unaudited financial results for the quarter and nine months ended December 31, 2023. It references SEBI regulations on insider trading and mentions the upcoming board meeting date will be intimated later. The document does not contain any financial data, results, or detailed report content. It is essentially an announcement related to compliance and trading restrictions prior to financial results disclosure. Given the short length (1602 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2023-12-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice about an Analyst/Investor meet scheduled by the company, referencing Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It explicitly states the meeting details and clarifies that no unpublished price sensitive information will be shared. The document is brief (1434 characters) and serves as an announcement of an event rather than a detailed report or transcript. It does not contain financial data, management discussion, or detailed presentation content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-21 English
Intimation of Analyst/Investors meet/ Interaction
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about an upcoming analyst/investor meeting with the company's senior management. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information. The content is an announcement of a scheduled investor interaction, explicitly stating no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report content included. The document length is short (1434 characters), and it serves as a notice rather than a report or transcript. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-12-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.